Swiss - Delayed Quote • CHF
Roche Holding AG (ROG.SW)
At close: April 26 at 5:31 PM GMT+2
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Severin Schwan Ph.D. | Executive Chairman | 7.51M | -- | 1967 |
Dr. Thomas Schinecker | Chief Executive Officer | 3.87M | -- | 1975 |
Dr. Alan Hippe | Chief Financial & Information Officer | 4.11M | -- | 1967 |
Dr. Bruno Eschli | Head of Investor Relations | -- | -- | -- |
Ms. Claudia Bockstiegel | General Counsel | -- | -- | 1964 |
Ms. Pascale Schmidt | Chief Compliance Officer | -- | -- | 1973 |
Ms. Barbara Schadler | Head of Group Communications | -- | -- | 1962 |
Ms. Cristina A. Wilbur | Chief People Officer | 2.92M | -- | 1967 |
Dr. Nicolas Dunant | Head of Group Media Relations | -- | -- | -- |
Mr. Boris L. Zaitra | Head of Group Business Development and M&A | -- | -- | 1972 |
Roche Holding AG
- Sector:
- Healthcare
- Industry: Drug Manufacturers - General
- Full Time Employees:
- 103,605
Description
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.
Corporate Governance
Roche Holding AG’s ISS Governance QualityScore as of April 1, 2024 is 8. The pillar scores are Audit: 4; Board: 6; Shareholder Rights: 9; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Mar 18, 2024Dividend Date
- Mar 14, 2024Ex-Dividend Date
Upcoming Events
Jul 25, 2024
Roche Holding AG Earnings Call
Related Tickers
NOVN.SW Novartis AG
89.50
-0.56%
BAYN.DE Bayer Aktiengesellschaft
27.40
+1.88%
SAN.PA Sanofi
91.23
-0.43%
NVS Novartis AG
97.44
-1.64%
SNY Sanofi
49.13
-0.47%
AZN.L AstraZeneca PLC
11,988.00
-0.32%
AZN AstraZeneca PLC
75.17
+0.19%
GSK.L GSK plc
1,653.00
+0.76%
BIIB Biogen Inc.
208.90
+3.18%
BMY Bristol-Myers Squibb Company
44.85
+0.34%